Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney.
暂无分享,去创建一个
D. Belin | A. Sappino | J. Vassalli | J. Huarte | J. Huarte | André-Pascal Sappino | Jean-Dominique Vassalli | Dominique Belin
[1] L. Gold,et al. Human plasma fibronectin as a substrate for human urokinase. , 1989, The Biochemical journal.
[2] D. Belin,et al. Plasminogen activators in the mouse mammary gland. Decreased expression during lactation. , 1989, The Journal of biological chemistry.
[3] W. Muellbacher,et al. Regulation of plasminogen activation in isolated perfused rat kidney. , 1989, The American journal of physiology.
[4] T. V. van Berkel,et al. Characterization of the interaction in vivo of tissue-type plasminogen activator with liver cells. , 1988, The Journal of biological chemistry.
[5] N. Bang,et al. Analysis of the plasminogen activator activity of the human glomerulus. , 1988, Kidney international.
[6] R. Rickles,et al. Molecular cloning of complementary DNA to mouse tissue plasminogen activator mRNA and its expression during F9 teratocarcinoma cell differentiation. , 1988, The Journal of biological chemistry.
[7] H. Holthöfer,et al. Plasminogen activators during differentiation of the human kidney. , 1987, Differentiation; research in biological diversity.
[8] D. Belin,et al. Plasminogen activator and mouse spermatozoa: urokinase synthesis in the male genital tract and binding of the enzyme to the sperm cell surface , 1987, The Journal of cell biology.
[9] D. Belin,et al. Amiloride selectively inhibits the urokinase‐type plasminogen activator , 1987, FEBS letters.
[10] K. Sakakibara,et al. Determination of urokinase in the urine of healthy volunteers and patients with renal diseases. , 1986, Thrombosis research.
[11] D. Belin,et al. Plasminogen activators and their inhibitors in a human mammary cell line (HBL-100). Modulation by glucocorticoids. , 1986, The Journal of biological chemistry.
[12] D. Rijken,et al. Specific fibrinolytic properties of different molecular forms of pro-urokinase from a monkey kidney cell culture. , 1986, Thrombosis research.
[13] D. Belin,et al. Plasminogen activator in mouse and rat oocytes: Induction during meiotic maturation , 1985, Cell.
[14] R. Duvoisin,et al. Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. , 1985, European journal of biochemistry.
[15] D. Belin,et al. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase , 1985, The Journal of cell biology.
[16] K. Danø,et al. Plasminogen activators, tissue degradation, and cancer. , 1985, Advances in cancer research.
[17] D. Belin,et al. Tumor promoter PMA stimulates the synthesis and secretion of mouse pro‐urokinase in MSV‐transformed 3T3 cells: this is mediated by an increase in urokinase mRNA content. , 1984, The EMBO journal.
[18] A. Vaheri,et al. Laminin interacts with plasminogen and its tissue‐type activator , 1984, FEBS letters.
[19] D. Belin,et al. Concomitant secretion of prourokinase and of a plasminogen activator- specific inhibitor by cultured human monocytes-macrophages , 1984, The Journal of experimental medicine.
[20] S. Thorsen,et al. Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysis. , 1984, European journal of biochemistry.
[21] K. Danø,et al. Human endothelial cells contain one type of plasminogen activator , 1984, FEBS letters.
[22] K. Danø,et al. Distribution of urokinase-type plasminogen activator immunoreactivity in the mouse , 1984, The Journal of cell biology.
[23] D. Lawrence,et al. Detection of an unusually stable fibrinolytic inhibitor produced by bovine endothelial cells. , 1983, Proceedings of the National Academy of Sciences of the United States of America.
[24] J. Chao,et al. Purification and characterization of rat urinary esterase A, a plasminogen activator. , 1983, The Journal of biological chemistry.
[25] D. Belin,et al. The production of distinct forms of plasminogen activator by mouse embryonic cells. , 1982, Developmental biology.
[26] R. Simmer,et al. Protease-nexin: A cellular component that links thrombin and plasminogen activator and mediates their binding to cells , 1980, Cell.
[27] J. Chao,et al. Amiloride inhibits mammalian renal kallikrein and a kallikrein-like enzyme from toad bladder and skin. , 1980, The Journal of clinical investigation.
[28] L. Ossowski,et al. Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue , 1979, Cell.
[29] A. Granelli‐Piperno,et al. A study of proteases and protease-inhibitor complexes in biological fluids , 1978, The Journal of experimental medicine.
[30] E. Reich. ACTIVATION OF PLASMINOGEN: A GENERAL MECHANISM FOR PRODUCING LOCALIZED EXTRACELLULAR PROTEOLYSIS , 1978 .
[31] J. Vassalli,et al. Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate , 1977, Cell.
[32] S. Strickland,et al. Plasminogen activator in early embryogenesis: Enzyme production by trophoblast and parietal endoderm , 1976, Cell.
[33] J. Unkeless,et al. SECRETION OF PLASMINOGEN ACTIVATOR BY STIMULATED MACROPHAGES , 1974, The Journal of experimental medicine.
[34] P. Vassalli,et al. The pathogenetic role of the coagulation process in glomerular diseases of immunologic origin. , 1971, Advances in nephrology from the Necker Hospital.
[35] R. Holemans,et al. Localization of plasminogen activator in kidney tissue. , 1966, Laboratory investigation; a journal of technical methods and pathology.
[36] A. Todd. LOCALIZATION OF FIBRINOLYTIC ACTIVITY IN TISSUES. , 1964, British medical bulletin.
[37] A. Ladehoff. The content of plasminogen activator in the human urinary tract. , 1960, Scandinavian journal of clinical and laboratory investigation.
[38] D. R. Celander,et al. Distribution of urokinase among the common mammals. , 1957, The American journal of physiology.
[39] I. Bjerrehuus. Fibrinolytic activity of urine. , 1952, Scandinavian journal of clinical and laboratory investigation.
[40] J. Pilling,et al. Fibrinolytic Activity of Normal Urine , 1947, Nature.
[41] M. Stoppelli,et al. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U 937 monocytes ( cell migration / phorbol ester / proteolysis ) , 2022 .